Pinealon 10mg

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

Quickstart Highlights

Pinealon is a synthetic tripeptide (Glu-Asp-Arg, the “EDR” sequence) from the Khavinson family of short-peptide bioregulators (“cytogens”), proposed to target the brain and central nervous system and historically associated with pineal/neuronal tissue[1][2]. This educational page outlines a once-daily subcutaneous approach with a dilution chosen so doses land on easy-to-read insulin-syringe marks. Important: documented human use of Pinealon is oral, and a subcutaneous schedule is not established in trials — the SC dosing here is educational/research-only, not clinically validated. It is an unapproved research chemical, not a medicine, presented for research and educational use only.

Add 3.0 mL bacteriostatic water to one 20 mg vial → ~6.67 mg/mL (6,667 mcg/mL).
200–500 mcg once daily, titrated upward gradually across a 12-week course. Note: SC dosing for Pinealon is not validated in trials.
At ~6.67 mg/mL, 1 unit ≈ 66.7 mcg; 200 mcg ≈ 3 units and 500 mcg ≈ 7.5 units on a U-100 syringe.
Lyophilized: store at −20 °C (−4 °F); once reconstituted, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the solution.
Important: Start with the Prep & Injection Guide — it covers the preparation and safety basics every protocol on this site assumes.

Dosing & Reconstitution Guide

A single practical dilution with accurate once-daily dosing, step by step

Standard / Gradual Approach (3 mL = ~6.67 mg/mL)

Phase / Week(s)	Dose & Frequency	Volume (U-100 units / mL)
Weeks 1–2	200 mcg (1× daily)	3 units (0.03 mL)
Weeks 3–4	300 mcg (1× daily)	4.5 units (0.045 mL)
Weeks 5–6	400 mcg (1× daily)	6 units (0.06 mL)
Weeks 7–12	500 mcg (1× daily)	7.5 units (0.075 mL)

Reconstitute: Add 3.0 mL bacteriostatic water to one 20 mg vial → final concentration ~6.67 mg/mL (6,667 mcg/mL).
Typical daily range: 200–500 mcg once daily, raised gradually over a 12-week course. This subcutaneous schedule is educational only — not established in human trials.
Easy measuring: At ~6.67 mg/mL, 1 unit ≈ 66.7 mcg on a U-100 syringe. Compute units as dose (mcg) ÷ 66.7 — e.g., 200 mcg ≈ 3 units, 500 mcg ≈ 7.5 units.
Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.
Frequency: one subcutaneous injection each day across a 12-week course, titrating up as tolerated. Important caveat: documented human use of Pinealon is oral, and subcutaneous administration has not been established in clinical trials[3][4]. This SC schedule is an educational illustration, not approved or validated human dosing.

Reconstitution Steps

Draw 3.0 mL of bacteriostatic water into a sterile syringe.

Release it slowly down the vial’s inner wall to limit foaming.
Swirl or roll gently until fully dissolved — don’t shake.
Label with the date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), shielded from light.
The 3.0 mL dilution keeps doses on readable U-100 syringe marks (compute units as mcg ÷ 66.7). Avoid freezing the reconstituted solution, since freeze–thaw can denature the peptide.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Quantities below assume a 12-week course of once-daily injections with gradual titration.

At 200–500 mcg once daily, a 20 mg vial covers many weeks of dosing; plan a small number of vials for a 12-week course.
One vial holds 20 mg (~6,667 mcg/mL after 3.0 mL)
12 weeks at 200–500 mcg/day: ~3–4 vials
Discard reconstituted solution after ~28 days
Per injection: 1 syringe
12 weeks (once daily): ~84 syringes
Use ~3.0 mL per 20 mg vial for reconstitution.
~3.0 mL per vial; ~3–4 vials over 12 weeks
About ~9–12 mL total → 1–2 bottles
One for the vial stopper + one for the injection site each day.
Per injection: 2 swabs
12 weeks (once daily): ~168 swabs → 1–2 boxes

Protocol Overview

A concise summary of the once-daily regimen, drawn from commonly cited reference protocols.

▪Goal: Explore the proposed brain/CNS-directed activity of the EDR tripeptide — effects are hypothesis-level, drawn from in-vitro and rodent work, and not independently established in humans[5][6].
▪Schedule: Once-daily subcutaneous injections for ~12 weeks (educational illustration; SC route not validated for Pinealon — documented human use is oral).
▪Dose Range: 200–500 mcg per day with gradual titration across the 12-week course.
▪Reconstitution: 3.0 mL bacteriostatic water per 20 mg vial gives ~6.67 mg/mL (1 unit ≈ 66.7 mcg).
▪Storage: Keep the dry vial frozen at −20 °C (−4 °F); once mixed, refrigerate at 2–8 °C and do not freeze the solution.

Dosing Protocol

A suggested daily titration approach based on common reference doses.

▪Start: Begin at 200 mcg once daily to gauge tolerability.
▪Titrate: Increase by roughly 100 mcg every two weeks as tolerated.
▪Target: Reach about 400–500 mcg daily by weeks 5–12.
▪Cycle Length: Commonly framed as a 12-week course. Remember: this subcutaneous schedule is not clinically validated for Pinealon.
▪Timing: Inject at a consistent time each day and rotate injection sites systematically.

Storage Instructions

Correct storage is what preserves the peptide’s stability and activity.

▪Lyophilized: Hold the dry vial at −20 °C (−4 °F) in dry, dark conditions and limit moisture exposure[7].
▪Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 28 days; do not freeze the mixed solution, as freezing can denature peptides[8].
▪Handling: Let frozen vials warm to room temperature before opening so condensation won’t form, and keep the solution clear of heat and direct light.
▪Freeze–thaw: Avoid repeated freeze–thaw cycles of the reconstituted solution.

Important Notes

Practical points that keep daily administration safe and consistent.

▪Sterile technique: Use a fresh sterile U-100 insulin syringe each time and drop it straight into a puncture-proof sharps container afterward.
▪Site rotation: Move between abdomen, thighs and upper arms to reduce local irritation and lipohypertrophy[9].
▪Slow injection: Push the plunger slowly and pause a few seconds before withdrawing the needle to prevent backflow.
▪Recordkeeping: Log the daily dose, injection site and any observations to keep the protocol consistent.
▪Regulatory note: Pinealon is not FDA/EMA-approved for human use and is research-only; as a non-approved peptide it falls under WADA’s S0 catch-all for athletes[10].

How This Works

Pinealon is a synthetic tripeptide with the sequence Glu-Asp-Arg (EDR)[1][2]. It belongs to the Khavinson group of short-peptide bioregulators (“cytogens”) and is described in that literature as targeting the brain and central nervous system, historically associated with pineal/neuronal tissue.

The proposed mechanism is hypothesis-level: short peptides of this family are suggested to interact with DNA/chromatin and influence gene expression (a peptide–epigenetic idea), with claimed downstream neuroprotective effects. This model originates largely with the Khavinson group and has not been independently established[5][6].
Reported findings are overwhelmingly in-vitro and rodent studies from the originating research group[11]. The single notable human report is a small (~72-patient) Russian study using oral Pinealon for sequelae of traumatic brain injury — there is no Western randomized controlled trial[12].
Important caveat: cognitive, neuroprotective, anti-aging and “organ-rejuvenation” claims for Pinealon are not established and should be read as hypotheses. Documented human use is oral; the subcutaneous schedule on this page is an educational illustration and is not clinically validated.
Pinealon is not an approved medicine. It is an unapproved research chemical presented here for research and educational purposes only.

Lifestyle Factors

General brain-health habits often discussed alongside research protocols (supportive context only — not Pinealon-specific effects).

▪Nutrition: Maintain a balanced, nutrient-dense diet that supports general brain and metabolic health.
▪Activity & rest: Regular physical activity and adequate rest are broadly associated with cognitive and CNS health.
▪Sleep: Aim for 7–9 hours to support memory consolidation and neural recovery.
▪Stress: Manage stress with evidence-based practices, since chronic stress affects cognition and brain health.

Potential Benefits & Side Effects

What the originating in-vitro and rodent literature describes; these are hypotheses, human evidence is minimal, and none are established benefits.

▪Neuroprotection (hypothesis): In-vitro and rodent reports from the originating group describe possible neuroprotective and antioxidant effects — not independently confirmed and not established in humans[5][6].
▪Cognitive claims (unproven): Cognitive/anti-aging and “organ-rejuvenation” claims circulate but rest on weak preclinical data and anecdote — treat as marketing hypotheses, not evidence[11].
▪Human report (oral): A single small (~72-patient) Russian study used oral Pinealon for TBI sequelae; it does not validate the subcutaneous route or general efficacy.
▪Note on humans: These effects are not established in humans — there is no Western randomized controlled trial of Pinealon[13].
▪Injection-site reactions: Mild redness, tenderness or soreness can occur; rotating sites helps.
▪Unknown long-term profile: Human safety data is limited, so caution and monitoring are advised.
▪Sport restriction: As a non-approved peptide, Pinealon falls under WADA’s S0 catch-all and is prohibited for athletes.

Injection Technique

General subcutaneous technique, following established clinical best-practice guidance[14][15].

▪Wash your hands well with soap and water.
▪Wipe the vial stopper with an alcohol swab and let it air-dry.
▪Choose a site (abdomen, thigh, or upper arm) and clean it with a fresh alcohol swab, letting it dry fully[15].
▪Draw the intended dose, then check for air bubbles and push any out.
▪Pinch a skinfold at the chosen site between thumb and forefinger.
▪Insert the needle into the pinch at a 45–90-degree angle (use 45 degrees if the fat layer is thin)[14].
▪Skip aspiration for subcutaneous shots — it isn’t needed[14].
▪Press the plunger slowly and steadily until it’s fully down.
▪Wait 5–10 seconds, then pull the needle straight out to prevent leakage.
▪Drop the used syringe straight into a puncture-proof sharps container — never recap a needle.
▪Return the reconstituted vial to the fridge right away.
▪Rotate the injection site each day to prevent irritation and lipohypertrophy[9].
▪Watch the site for excess redness, swelling, or signs of infection.

Recommended Source

For high-purity research peptides, we point researchers to Prime Lab Peptides.

▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA. Open source
▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.
▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.
▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.
▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
Shop at Prime Lab Peptides →

References

Reference-derived details for Pinealon 10mg.

Pinealon (20mg Vial) Dosage Protocol Open source
1 Khavinson — Peptides and Ageing (review) Foundational review of short-peptide bioregulators (cytogens) including Glu-Asp-Arg (EDR); mechanism remains hypothesis-level. View Source ↗ Open source
2 PubChem — Glu-Asp-Arg (EDR tripeptide) Chemical identity of the synthetic tripeptide Glu-Asp-Arg associated with Pinealon. View Source ↗ Open source
3 FDA — Unapproved drug / research-chemical status Pinealon is not FDA-approved for human use; research chemicals are not for human consumption. View Source ↗ Open source
4 EMA — No marketing authorisation No EMA marketing authorisation exists for Pinealon; not an approved medicine in the EU. View Source ↗ Open source
5 Khavinson group — EDR neuroprotection (preclinical) In-vitro / rodent reports of proposed neuroprotective and antioxidant effects of the EDR peptide; not independently confirmed. View Source ↗ Open source
6 Peptide–DNA / epigenetic hypothesis (preclinical) Proposed interaction of short peptides with DNA/chromatin to modulate gene expression — a hypothesis from the originating group. View Source ↗ Open source
7 Peptide Storage Guide Best practices for storing lyophilized peptides (temperature, humidity and light protection). View Source ↗ Open source
8 Bacteriostatic Water Guidance Bacteriostatic water for injection: multi-dose vial stability and handling. View Source ↗ Open source
9 NCBI Bookshelf Best practices for subcutaneous injection: aseptic technique and site rotation. View Source ↗ Open source
10 WADA Prohibited List (S0) Non-approved substances such as research peptides fall under the S0 catch-all and are prohibited in sport. View Source ↗ Open source
11 In-vitro / rodent literature (originating group) Most Pinealon findings derive from in-vitro and animal studies by the originating research group; limited external replication. View Source ↗ Open source
12 Russian oral Pinealon TBI study (~72 patients) Small clinical report using oral Pinealon for sequelae of traumatic brain injury; no Western randomized controlled trial exists. View Source ↗ Open source
13 ClinicalTrials.gov Trial registry search for Pinealon / Glu-Asp-Arg; no completed Western efficacy trials. View Source ↗ Open source
14 Centers for Disease Control and Prevention (CDC) Subcutaneous injection technique: angle, site and no-aspiration guidance. View Source ↗ Open source
15 Subcutaneous Injection Technique (Patient Education) How to administer a subcutaneous injection: clinical technique guidelines. View Source ↗ Open source
16 Prime Lab Peptides Research-peptide supplier — purity specifications and certificates of analysis. View Source ↗ Open source

Contents